Emerging approaches to dyslipidemia management beyond LDL-c - PACE-CME

Emerging approaches to dyslipidemia management beyond LDLc

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

The remaining challenges in lowering LDL-c in patients at increased CV risk
The remaining challenges in lowering LDL-c in patients at increased CV risk
MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program credits
- Prof. Kausik Ray
0.75 program credits
Novel oral LDL-c lowering therapies on the horizon: CETP inhibition
Novel oral LDL-c lowering therapies on the horizon: CETP inhibition
MinuteCE®
Novel oral LDL-c lowering therapies on the horizon: CETP inhibition
0.75 program credits
- Ulrich Laufs, MD, PhD
0.75 program credits
The case for early LDL-c lowering in patients at increased CV risk: When should we start?
The case for early LDL-c lowering in patients at increased CV risk: When should we start?
MinuteCE®
The case for early LDL-c lowering in patients at increased CV risk: When should we start?
0.75 program credits
- Pasquale Perrone-Filardi, MD, PhD
0.75 program credits
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 program credits
- John Kastelein, MD, PhD
0.50 program credits